The Pharma Data

MAY 16, 2021

Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups. High immune response after a single dose in patients with prior infection shows strong booster potential. For media and investors only. Issued: London UK. About the Phase 2 study.

Immune Response 52

Immune Response Vaccine Vaccination Trials 52

XTalks

APRIL 7, 2021

The test is intended for the detection of COVID-19 infection, either a recent or previous infection, as detected through an adaptive antibody immune response to SARS-CoV-2. The test involves self-collection of a fingerstick dried blood sample.

Antibody 102

Antibody Immune Response Radiology Marketing 102

The Pharma Data

DECEMBER 23, 2020

All 38 subjects who were evaluable for immunogenicity had balanced cellular and humoral immune responses following the second dose of INO-4800. The antigen is processed naturally in the cell and triggers the desired T cell and antibody-mediated immune responses. It will be funded by the U.S.

DNA 40

DNA Vaccine Vaccination Immune Response 40

Cloudbyz

JULY 31, 2024

This includes tracking the persistence and function of modified cells, detecting any adverse immune responses, and ensuring that the therapeutic effects are sustained over time. Automated Image Analysis: In fields like radiology and pathology, AI-powered image analysis tools can detect subtle changes and anomalies with high accuracy.

Gene Therapy 52

Gene Therapy Gene Medicine In-Vitro 52

XTalks

MARCH 10, 2021

Adaptive Biotechnologies’ T-Detect COVID Test is a next-generation sequencing (NGS) test that can indicate recent or prior infection with SARS-CoV-2 through detection of a T cell immune response to the virus. This is the first T cell test of its kind for the detection of COVID-19 infection.

Protein 98

Protein RNA Antibody Production 98

Bioengineer

JULY 15, 2021

But some patients develop resistance to current immunotherapies and others have cancers characterized by immunologically “cold” tumors, which evade or suppress the patient’s immune response against his or her cancer. This agent was developed by one of the co-authors, Jamey Weichert, Ph.D.,

Medicine 52

Medicine Clinical Trials Clinical Trials Scientist 52

The Pharma Data

MARCH 29, 2022

W911QY-21-9-0001. AstraZeneca AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Antibody 52

Antibody In-Vivo Vaccine Vaccination 52